338 related articles for article (PubMed ID: 15029891)
21. Schedules of Controlled Substances: Temporary Placement of N-Ethylpentylone in Schedule I. Temporary amendment; temporary scheduling order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2018 Aug; 83(170):44474-8. PubMed ID: 30198687
[TBL] [Abstract][Full Text] [Related]
22. Schedules of Controlled Substances: Placement of Three Synthetic Phenethylamines Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Sep; 81(187):66181-4. PubMed ID: 27726316
[TBL] [Abstract][Full Text] [Related]
23. Classification of three steroids as schedule III anabolic steroids under the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2009 Dec; 74(232):63603-10. PubMed ID: 20169675
[TBL] [Abstract][Full Text] [Related]
24. Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Aug; 79(167):51243-7. PubMed ID: 25167596
[TBL] [Abstract][Full Text] [Related]
25. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Feb; 79(27):7577-82. PubMed ID: 24605391
[TBL] [Abstract][Full Text] [Related]
26. Schedules of controlled substances: removal of naloxegol from control. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Jan; 80(15):3468-70. PubMed ID: 25730920
[TBL] [Abstract][Full Text] [Related]
27. Schedules of controlled substances: extension of temporary placement of methylone into schedule I of the Controlled Substances Act. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2012 Oct; 77(202):64032-3. PubMed ID: 23077760
[TBL] [Abstract][Full Text] [Related]
28. Control of immediate precursor used in the illicit manufacture of fentanyl as a schedule II controlled substance. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2010 Jun; 75(124):37295-9. PubMed ID: 20608285
[TBL] [Abstract][Full Text] [Related]
29. Definition of "positional isomer" as it pertains to the control of schedule I controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Dec; 72(231):67850-2. PubMed ID: 18064769
[TBL] [Abstract][Full Text] [Related]
30. Schedules of Controlled Substances: Removal of [123I]Ioflupane From Schedule II of the Controlled Substances Act. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Sep; 80(176):54715-8. PubMed ID: 26364325
[TBL] [Abstract][Full Text] [Related]
31. Schedules of Controlled Substances: Placement of MT-45 Into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice.
Fed Regist; 2017 Dec; 82(238):58557-9. PubMed ID: 29235771
[TBL] [Abstract][Full Text] [Related]
32. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Aug; 79(163):49661-82. PubMed ID: 25167591
[TBL] [Abstract][Full Text] [Related]
33. Schedules of Controlled Substances: Temporary Placement of Acetyl Fentanyl Into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Jul; 80(137):42381-5. PubMed ID: 26189217
[TBL] [Abstract][Full Text] [Related]
34. Designation of oripavine as a basic class of controlled substance. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2007 Sep; 72(184):54208-10. PubMed ID: 17912784
[TBL] [Abstract][Full Text] [Related]
35. Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Mar; 79(45):12938-43. PubMed ID: 24611212
[TBL] [Abstract][Full Text] [Related]
36. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
[TBL] [Abstract][Full Text] [Related]
37. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Jan; 80(20):5042-7. PubMed ID: 25730924
[TBL] [Abstract][Full Text] [Related]
38. Placement of gamma-butyrolactone in List I of the Controlled Substances Act (21 U.S.C. 802(34)). Drug Enforcement Administration, Justice. Final rule.
Fed Regist; 2000 Apr; 65(79):21645-7. PubMed ID: 11010670
[TBL] [Abstract][Full Text] [Related]
39. Schedules of Controlled Substances: Temporary Placement of the Synthetic Cannabinoid MAB-CHMINACA Into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Feb; 81(24):6171-5. PubMed ID: 26859902
[TBL] [Abstract][Full Text] [Related]
40. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
Drug Enforcement Administration (DEA), Justice
Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
